Image de couverture de livre

Biosynthesis of Natural and Unnatural Perylenequinones for Drug Development

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Zengping Su, Yan Zhang, Zhenbo Yuan, Yijian Rao
Format:	Artículo Open Access
Publié:	Wiley 2024
Sujets:	ChemMedChem
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Small Molecule‐Drug Conjugates: Opportunities for the Development of Targeted Anticancer Drugs
par: Jingjing Zhang, et autres
Publié: (2024)

Current Approaches and Strategies Applied in First‐in‐class Drug Discovery
par: Idrees Mohammed, et autres
Publié: (2024)

Bacterial Secondary Metabolites Embedded in Producer Cell Membranes and Antibiotics Targeting Their Biosynthesis
par: Zhao Xia, et autres
Publié: (2024)

Corrin Ring Modification in Peptide Drug Development – a Brief History of “Corrination”
par: Nancy Cham, et autres
Publié: (2025)

“Cofactors” for Natural Products
par: Shao‐Lun Chiou, et autres
Publié: (2025)

Exploiting Pharmacokinetic/Pharmacodynamic Methods for Optimizing and Accelerating Drug Development of Innovative Anti‐Infectives
par: Katharina Rox
Publié: (2026)

Naturally Occurring and Widespread Resistance to Bioactive Natural Products
par: Bin Tan, et autres
Publié: (2024)

Sertraline as a Scaffold for Antitrypanosoma Cruzi Drug Development: Design of Novel Derivatives and Computational Target Screening
par: Ali S. Mijoba, et autres
Publié: (2025)

Conjugating Daunorubicin and Doxorubicin to GTP by Formaldehyde to Overcome Drug Resistance
par: Linjia Su, et autres
Publié: (2024)

Harnessing Chemical Diversity to Disarm Bacterial Communication for 25 Years: Natural Products, Repurposed Drugs, Peptides, and Synthetic Quorum Sensing Inhibitors
par: Tung Truong‐Thanh, et autres
Publié: (2025)

API‐ILs Ionic Adducts: Solubility and Surface Activity Properties—En Route to New Paradigm in Drug Development
par: Janusz Nowicki, et autres
Publié: (2025)

Targeting N‐Methyl‐lysine Histone Demethylase KDM4 in Cancer: Natural Products Inhibitors as a Driving Force for Epigenetic Drug Discovery
par: Ilaria Cursaro, et autres
Publié: (2024)

Drugging Protein Tyrosine Phosphatases through Targeted Protein Degradation
par: Jinmin Miao, et autres
Publié: (2024)

Front Cover: r‐BRICS – A Revised BRICS Module That Breaks Ring Structures and Carbon Chains (ChemMedChem 4/2024)
par: Leili Zhang, et autres
Publié: (2024)

Front Cover: Corrin Ring Modification in Peptide Drug Development – a Brief History of “Corrination” (ChemMedChem 10/2025)
par: Nancy Cham, et autres
Publié: (2025)

Accelerating Drug Discovery through Knowledge Sharing
par: Rory C. McAtee
Publié: (2026)

Exploring Synthesis Strategies and Interactions between MOFs and Drugs for Controlled Drug Loading and Release, Characterizing Interactions through Advanced Techniques
par: Lidia E. Chiñas‐Rojas, et autres
Publié: (2024)

Recent Progress on Topical Drug Therapy for Corneal Neovascularization
par: Xin‐Can Huang, et autres
Publié: (2025)

Mitochondria‐Targeting Metallodrugs for Cancer Therapy: Perspectives from Cell Death Modes
par: Hao‐Ming Li, et autres
Publié: (2024)

A Metal–Organic Nanoplatform Coassembled with Artesunate and Chlorin e6 for Synergistic Chemo/Photodynamic Cancer Therapy
par: Ling Yang, et autres
Publié: (2026)

Linker Design for the Antibody Drug Conjugates: A Comprehensive Review
par: Yaxin Lei, et autres
Publié: (2025)

Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry
par: Sadık Hüseyin Cemali, et autres
Publié: (2025)

Enhancing Targeted Drug Delivery through Cell‐Specific Endosomal Escape
par: Pengwen Chen, et autres
Publié: (2024)

Drug Discovery Summit: 14 th Swiss Course on Medicinal Chemistry
par: Céline Schuppisser, et autres
Publié: (2024)

Hybrid Molecules as Efficient Drugs against Multidrug‐Resistant Malaria Parasites
par: Anne Robert, et autres
Publié: (2025)

The Multifaceted Legacy of Thalidomide: Chemistry and Biology Driving Modern Drug Design
par: Konstantina Nikovia, et autres
Publié: (2026)

Direct‐to‐Biology: Streamlining the Path From Chemistry to Biology in Drug Discovery
par: Ariane F. Hübner, et autres
Publié: (2026)

Insights Into Vepdegestrant (ARV‐471): The First‐in‐Class Estrogen Receptor Proteolysis‐Targeting Chimera Approaching Food and Drug Administration Approval for Breast Cancer
par: Chao Tang, et autres
Publié: (2026)

Fluorescence‐Based HTS Assays for Ion Channel Modulation in Drug Discovery Pipelines
par: Jan Voldřich, et autres
Publié: (2024)

Nonsteroidal Anti‐Inflammatory Drugs as Modulators of Cation Channels: Fenamates Repurposing in Channelopathies
par: Paola Laghetti, et autres
Publié: (2025)

Design, Synthesis, and Biological Evaluation of Evodiamine Derivatives as Antibody–Drug Conjugate Payloads
par: Ruifeng Liu, et autres
Publié: (2025)

A New Paradigm for Drug Deuteration Based on Computed Binding Isotope Effects
par: Agata Paneth, et autres
Publié: (2025)

Imidazole‐Based Liposomes: Emerging pH‐Sensitive Drug Delivery Tools
par: Faeze Shojaeinia, et autres
Publié: (2025)

Discovery of Fluorescent Naturally‐Occurring Inhibitor of SARS‐CoV‐2 Main Protease by AIE Fluorescent Probe
par: Hao Lin, et autres
Publié: (2024)

Azologs of the Fatty Acid Mimetic Drug Cinalukast Enable Light‐Induced PPARα Activation
par: Minh Sai, et autres
Publié: (2024)

How to Find a Fragment: Methods for Screening and Validation in Fragment‐Based Drug Discovery
par: Tim Kirkman, et autres
Publié: (2024)

Exploring the Utility of Cell‐Penetrating Peptides as Vehicles for the Delivery of Distinct Antimalarial Drug Cargoes
par: Caitlin L. Gare, et autres
Publié: (2024)

Strategic Design and Development of Indole‐Based Compounds as Potent Malic Enzyme 3 Inhibitors for Pancreatic Tumor Therapy
par: Gaurav Sheth, et autres
Publié: (2025)

Natural Staurosporine Derivatives with Fluorescence for Cancer Theranostics
par: Kualiang Li, et autres
Publié: (2025)

Structure–Property Associations: Breaking Paradigms for Linking Chemical Structures and Biological Properties in Drug Discovery
par: Edgar López‐López, et autres
Publié: (2025)